Cell Counting Market Figures and Analytical Insights Forecast 2022-2031￼￼
The cell counting market is projected to register a CAGR of 6.6% over the forecast period. The major factor attributing to the growth of the market is the rising incidence of target diseases, like HIV, measles, diphtheria, and chronic diseases like cancer and other blood disorders.
– According to the World Health Organization (WHO), it is estimated that in 2018, nearly 37.9 million individuals had HIV, globally. It has been identified that most of this prevalence is in low and middle-income countries, with an estimated 66% living in sub-Saharan Africa. As per a report published by Meryem Jefferies et al. in the World Journal of Clinical Cases 2018, every year 1.4 million people die from viral hepatitis-related cirrhosis and liver cancer. Thus, rising cases of infectious diseases are ultimately expected to increase the demand in the cell counting market.
Get a Sample Copy of this Report with Graphs and Charts: https://www.sdki.jp/sample-request-89328
Key Market Trends
The Instruments Segment is Expected to Dominate the Market
The dominant share of the segment is attributed to the increasing usage of the cell counters in various applications, like research, diagnostics, and industrial. Cell counting instruments are increasingly being adopted in various areas of research, such as cancer biology, immunology, and neuroscience, which displays exponential growth opportunities for the market. Increasing chronic diseases increase the demand for the instruments.
According to the UNAIDS, 37.9 million people globally were affected with HIV, 1.7 million became newly infected with HIV, and 770 000 people died from AIDS-related illnesses by the end of 2018. The increasing patient pool and increasing research and development propelled the market growth.
North America Dominates the Market and is Expected to do Same in the Forecast Period
North America is expected to dominate the overall cell counting market, throughout the forecast period. The largest share is mainly due to the presence of a larger patient pool and increasing geriatric population. In the North America region, the United States holds the largest market share due to factors, such as the increasing number of chronic diseases, along with a growing number of research and development programs in the country. According to the latest estimates from the Centers for Disease Control and Prevention, 37,832 people received HIV diagnosis in the United States, in 2018. As per the statistics, the large patient pool and high disposable income propelled the market growth in the region.
Request for PDF Sample Copy: – https://www.sdki.jp/sample-request-89328
The cell counting market is moderately competitive. A few of the crucial approaches followed by players are product advancement, invention, acquisitions, and mergers. Some of the companies currently dominating the market are Beckman Coulter Inc., Thermo Fisher Scientific, Becton, Dickinson and Company, Merck, Bio-Rad Laboratories, and GE Healthcare.
The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.
–Related Trending Reports:-
Sports Analytics market
China Smart Cities market
smart robots market
web analytics market
IoT in Smart Cities market
Internet of Things (IoT) in Retail market
TV Analytics market
PC as a Service market
IoT Device Management market